Business Tilray re-brands therapeutic divisions as Tilray Medical The firm says Canadian patients will get broader access to its products, as it continues to push for international growth Natalia Buendia CalvilloFebruary 8, 2022
News Hexo to buy 48North Cannabis for $50M Amid a wave of consolidation, the Ottawa firm says the deal will give it a top-2 position in the Canadian adult-use weed market Jared GnamMay 17, 2021
Canada Aurora stock falls amid more large losses and cost cuts With a massive $164.7M Q3 loss and a second round of cuts, the Edmonton producer is illustrative of troubles in the Canadian cannabis industry Jared GnamMay 14, 2021
News Tilray 1.0 quietly discloses first-quarter US$341M loss In the final quarter before merging with Aphria, Tilray shows fiscal weakness Jared GnamMay 11, 2021
Analysis Writedowns and growing pains ahead for Tilray 2.0, analyst says But Chris Damas of the BCMI Cannabis Report notes the Aphria-merged firm will command a strong presence in Europe's medical cannabis market Jared GnamMay 3, 2021
Industry update Valens enters US CBD market with purchase of Florida firm The Canadian pot product company says its Green Roads deal represents only the first step in its US expansion strategy Jared GnamApril 27, 2021
Industry update Tilray reduces required shareholder vote count to 1/3 for Aphria merger The Canadian weed firm urges all shareholders to weigh in on the vote, which has been delayed to April 30 Jared GnamApril 16, 2021
Industry update Aphria blames slump on Covid despite steady market growth CEO Simon says he expects to capture 30% of a $6B Canadian market following the Tilray merger and pandemic lifting Nick LabaApril 12, 2021
Canada How Aphria is fighting for more market share: marketing VP Q&A Although the Canadian company leads across several categories and jurisdictions, it's battling against price compression and packaging costs to win Nick LabaApril 9, 2021
Industry update Can you buy brand loyalty? Canopy thinks so While Canopy says its building authentic brands, weed industry insiders criticize the pot giant for attempting to buy brand loyalty instead of earning it Jared GnamApril 1, 2021